|Last Price$33.66||Day Change (%)-2.01%|
|Open Price$33.67||Day Change ($)-0.69|
|Day Range33.62–35.00||52-Week Range12.17–35.00|
As of Fri 01/30/2015 05:33 PM EST | USD
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...
AbbVie announces positive Phase 3 trial of endometriosis treatment
UPDATE: Biogen, Constellation gain; Family Dollar, Alexion drop